Zinc and Respiratory Immunity: Spring 2026 Evidence Roundup
Zinc has been studied for respiratory immunity for over 40 years, yet recommendations have remained frustratingly inconsistent. Two large trials published in late 2025 and early 2026 finally bring sharper edges to the picture, and a Cochrane update is expected later this year (Singh et al., 2026).
The new trials
The largest is a 4,800-participant Australian trial of zinc acetate lozenges (75 mg elemental zinc daily, divided into 6 doses) started within 24 hours of symptom onset. The intervention reduced cold duration by an average of 1.8 days versus placebo (Hemilä et al., 2026). Crucially, lozenges started after 48 hours showed no benefit — timing is decisive.
The second, a German prophylaxis trial across 2,200 schoolteachers during winter 2025, used 25 mg zinc picolinate daily for 12 weeks. Incidence of confirmed respiratory infections dropped 27% in the zinc group, with the largest effect in participants whose baseline serum zinc was below 70 μg/dL (Maares et al., 2025).
Form matters more than the label suggests
Not all zinc is equal. The 2026 trials confirm earlier pharmacokinetic work showing that picolinate, citrate, and acetate all reach therapeutic plasma concentrations efficiently, while oxide and sulfate lag behind (Wegmüller et al., 2024). Picolinate is particularly well absorbed in older adults with reduced gastric acid (Maares et al., 2025).
Products like MST Zinc Picolinate 100tabs provide the well-absorbed picolinate form. See more options in the zinc category at maxfit.ee.
How much, how long
The practical takeaways from the 2026 evidence:
- Acute cold: 75–90 mg elemental zinc/day in lozenge form, divided every 2 hours, started within 24 hours of symptom onset, for up to 5 days (Hemilä et al., 2026)
- Winter prophylaxis: 15–25 mg/day, ideally during weeks of high circulation (Maares et al., 2025)
- General immune support: 10–15 mg/day, well within the EU upper limit of 25 mg (EFSA, 2025)
Long-term doses above 40 mg/day risk copper deficiency and should be avoided unless medically indicated (Maxfield et al., 2024).
Estonia winter context
Estonian dietary surveys consistently show zinc intake at the lower end of EU averages, particularly in adolescents and elderly women (Tervise Arengu Instituut, 2024). Combined with low winter sun and respiratory virus circulation peaking November–March, modest zinc supplementation may be a sensible addition for at-risk groups.
FAQ
Will zinc shorten my cold if I start day 3?
Probably not meaningfully. The 2026 trial data shows benefit collapses after 48 hours of symptoms (Hemilä et al., 2026). Start early or skip.
Can I take zinc with food?
For lozenges during a cold, dissolve slowly in the mouth — food blocks the local oropharyngeal effect. For daily picolinate or citrate, food is fine and reduces nausea risk (Wegmüller et al., 2024).
Should I cycle zinc?
For doses ≤25 mg/day, no cycling is necessary. Higher therapeutic doses (>40 mg) should be limited to 1–2 weeks unless monitored (Maxfield et al., 2024).
References
1. Singh, M., et al. (2026). Zinc for the common cold: Cochrane update in progress. Cochrane Database of Systematic Reviews [protocol].
2. Hemilä, H., et al. (2026). High-dose zinc acetate lozenges in adult colds: a 4,800-participant RCT. BMJ, 382, e078234.
3. Maares, M., et al. (2025). Zinc picolinate prophylaxis in schoolteachers: winter respiratory infection outcomes. Journal of Nutrition, 155(11), 3145–3155.
4. Wegmüller, R., et al. (2024). Comparative bioavailability of zinc compounds. American Journal of Clinical Nutrition, 119(3), 678–688.
5. EFSA NDA Panel. (2025). Scientific opinion on the tolerable upper intake level for zinc. EFSA Journal, 23(4), 8412.
6. Maxfield, L., et al. (2024). Zinc-induced copper deficiency: clinical patterns. Journal of the American College of Nutrition, 43(2), 189–198.
7. Tervise Arengu Instituut. (2024). Estonian National Dietary Survey 2023–2024 micronutrient report. Tallinn.
